|
FENC Fennec Pharmaceuticals Inc 1211583 |
| Balance Sheet |
|
Current Assets
|
$72,500,000.00 |
|
Assets
|
$75,753,000.00 |
|
Current Liabilities
|
$12,394,000.00 |
|
Liabilities
|
$33,311,000.00 |
|
Equity
|
$42,442,000.00 |
|
Shares Out
|
35034000.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$2,429,000.00 |
| Market Analysis |
Market Cap
|
$397,635,900.00 |
|
Price
|
$11.35 |
|
BVPS
|
1.21 |
|
PB
|
9.38 |
|
EPS
|
0.06 |
|
PS
|
16.72 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:43 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:34 |
|
| Apr |
May |
Jun |
| 2026-03-24 |
-0.17 |
|
|
2026-05-14 |
0.01 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-14 |
-0.11 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-13 |
-0.02 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view FENC documents filed with the SEC.
FENC Filings
Clear
